Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viewray, Inc. (VRAY) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viewray, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1597313.
Total stock buying since 2016: $89,501,106.
Total stock sales since 2016: $159,242,488.
Total stock option exercises since 2016: $792,105.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 0 | $0 | 13,529,227 | $1,016,019 | 167,000 | $125,250 |
2022 | 1,981,970 | $5,181,381 | 0 | $0 | 0 | $0 |
2021 | 147,142 | $812,794 | 16,600,000 | $107,502,000 | 0 | $0 |
2020 | 155,000 | $499,875 | 0 | $0 | 0 | $0 |
2019 | 13,290,300 | $41,741,293 | 306,175 | $1,234,814 | 301,029 | $206,655 |
2018 | 2,787,702 | $25,549,943 | 3,711,739 | $38,986,166 | 166,821 | $386,144 |
2017 | 1,114,986 | $3,422,108 | 1,385,274 | $10,503,489 | 25,104 | $74,056 |
2016 | 4,167,361 | $12,293,712 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2023-07 | 0 | $0 | 13,487,227 | $842,559 | 0 | $0 |
2023-03 | 0 | $0 | 42,000 | $173,460 | 167,000 | $125,250 |
2022-11 | 25,000 | $117,275 | 0 | $0 | 0 | $0 |
2022-05 | 1,931,970 | $4,968,211 | 0 | $0 | 0 | $0 |
2022-03 | 25,000 | $95,895 | 0 | $0 | 0 | $0 |
2021-11 | 107,142 | $599,994 | 8,000,000 | $56,160,000 | 0 | $0 |
2021-08 | 40,000 | $212,800 | 0 | $0 | 0 | $0 |
2021-06 | 0 | $0 | 8,600,000 | $51,342,000 | 0 | $0 |
2020-11 | 155,000 | $499,875 | 0 | $0 | 0 | $0 |
2019-12 | 13,099,040 | $40,999,994 | 0 | $0 | 0 | $0 |
2019-09 | 0 | $0 | 279,414 | $996,390 | 279,414 | $191,957 |
2019-08 | 191,260 | $741,299 | 21,615 | $193,994 | 21,615 | $14,698 |
2019-07 | 0 | $0 | 5,146 | $44,430 | 0 | $0 |
2018-11 | 85,000 | $549,950 | 0 | $0 | 0 | $0 |
2018-08 | 2,702,702 | $24,999,993 | 3,021,209 | $31,075,463 | 91,578 | $325,950 |
2018-07 | 0 | $0 | 615,287 | $7,340,964 | 0 | $0 |
2018-03 | 0 | $0 | 75,243 | $569,739 | 75,243 | $60,194 |
2017-12 | 0 | $0 | 0 | $0 | 25,104 | $74,056 |
2017-04 | 0 | $0 | 1,242,736 | $9,280,764 | 0 | $0 |
2017-03 | 0 | $0 | 142,538 | $1,222,725 | 0 | $0 |
2017-01 | 1,114,986 | $3,422,108 | 0 | $0 | 0 | $0 |
2016-09 | 1,472,803 | $4,344,768 | 0 | $0 | 0 | $0 |
2016-08 | 2,694,558 | $7,948,944 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-07-21 | Shah Sanket (SVP, General Counsel) | Sale | 30,364 | .07 | 2,277 |
2023-07-21 | Prange Karen (Director) | Sale | 37,600 | .05 | 1,917 |
2023-07-21 | Johnson B Kristine (Director) | Sale | 30,702 | .05 | 1,596 |
2023-07-20 | Ebrahimi Farhad Fred | Sale | 8,203,610 | .06 | 492,216 |
2023-07-19 | Ziegler Paul Jr (Chief Executive Officer) | Sale | 169,785 | .07 | 12,224 |
2023-07-19 | Prange Karen (Director) | Sale | 91,866 | .07 | 6,889 |
2023-07-19 | Castelein Caley (Director) | Sale | 2,345,030 | .07 | 164,152 |
2023-07-18 | Drake Scott William (Director) | Sale | 2,408,747 | .06 | 149,342 |
2023-07-18 | Johnson B Kristine (Director) | Sale | 79,622 | .07 | 5,653 |
2023-07-17 | Podbelski Adam Andrew (SVP, Customer Services) | Sale | 89,901 | .07 | 6,293 |
2023-03-07 | Dempsey James F. (Chief Scientific Officer) | Option Ex | 125,000 | .75 | 93,750 |
2023-03-03 | Dempsey James F. (Chief Scientific Officer) | Sale | 42,000 | 4.13 | 173,460 |
2023-03-03 | Dempsey James F. (Chief Scientific Officer) | Option Ex | 42,000 | .75 | 31,500 |
2022-11-28 | Schnabel Susan C | Buy | 25,000 | 4.69 | 117,275 |
2022-05-20 | Schnabel Susan C | Buy | 20,000 | 2.93 | 58,520 |
2022-05-19 | Schnabel Susan C | Buy | 10,000 | 2.89 | 28,900 |
2022-05-18 | Roberts Brian K | Buy | 16,000 | 2.98 | 47,680 |
2022-05-12 | Johnson B Kristine | Buy | 40,000 | 2.82 | 112,720 |
2022-05-12 | Schnabel Susan C | Buy | 5,000 | 2.75 | 13,750 |
2022-05-11 | Stassen Zachary William (Chief Financial Officer) | Buy | 20,000 | 2.49 | 49,760 |
2022-05-11 | Drake Scott William (President & CEO) | Buy | 117,012 | 2.53 | 295,572 |
2022-05-11 | Castelein Caley | Buy | 1,065,000 | 2.54 | 2,701,905 |
2022-05-10 | Stassen Zachary William (Chief Financial Officer) | Buy | 100,000 | 2.69 | 268,500 |
2022-05-10 | Prange Karen | Buy | 37,600 | 2.66 | 99,940 |
2022-05-10 | Drake Scott William (President & CEO) | Buy | 40,000 | 2.61 | 104,480 |
2022-05-10 | Moore Daniel Jeffrey | Buy | 96,358 | 2.60 | 250,049 |
2022-05-10 | Castelein Caley | Buy | 350,000 | 2.57 | 899,500 |
2022-05-10 | Schnabel Susan C | Buy | 5,000 | 2.56 | 12,785 |
2022-05-09 | Schnabel Susan C | Buy | 10,000 | 2.42 | 24,150 |
2022-03-11 | Schnabel Susan C | Buy | 15,000 | 3.88 | 58,185 |
2022-03-10 | Schnabel Susan C | Buy | 10,000 | 3.77 | 37,710 |
2021-11-19 | Stassen Zachary William (Chief Financial Officer) | Buy | 17,857 | 5.60 | 99,999 |
2021-11-19 | Drake Scott William (President & CEO) | Buy | 89,285 | 5.60 | 499,995 |
2021-11-08 | Strong Influence Ltd | Sale | 4,000,000 | 7.02 | 28,080,000 |
2021-11-08 | Fosun International Ltd | Sale | 4,000,000 | 7.02 | 28,080,000 |
2021-08-24 | Stassen Zachary William (Chief Financial Officer) | Buy | 40,000 | 5.32 | 212,800 |
2021-06-08 | Strong Influence Ltd | Sale | 4,300,000 | 5.97 | 25,671,000 |
2021-06-08 | Fosun International Ltd | Sale | 4,300,000 | 5.97 | 25,671,000 |
2020-11-10 | Drake Scott William (President & CEO) | Buy | 155,000 | 3.23 | 499,875 |
2019-12-06 | Strong Influence Ltd | Buy | 5,750,798 | 3.13 | 17,999,997 |
2019-12-06 | Fosun International Ltd | Buy | 7,348,242 | 3.13 | 22,999,997 |
2019-09-03 | Dempsey James F. (Chief Scientific Officer) | Sale | 279,414 | 3.57 | 996,390 |
2019-09-03 | Dempsey James F. (Chief Scientific Officer) | Option Ex | 279,414 | .69 | 191,957 |
2019-08-14 | Matin Shahriar (Chief Operating Officer) | Buy | 60,000 | 4.02 | 241,199 |
2019-08-13 | Drake Scott William (President & CEO) | Buy | 131,260 | 3.81 | 500,100 |
2019-08-01 | Dempsey James F. (Chief Scientific Officer) | Sale | 21,615 | 8.97 | 193,994 |
2019-08-01 | Dempsey James F. (Chief Scientific Officer) | Option Ex | 21,615 | .68 | 14,698 |
2019-07-01 | Dempsey James F. (Chief Scientific Officer) | Sale | 5,146 | 8.63 | 44,430 |
2018-11-13 | Drake Scott William (President & CEO) | Buy | 60,000 | 6.47 | 388,200 |
2018-11-13 | Matin Shahriar (Chief Operating Officer) | Buy | 25,000 | 6.47 | 161,750 |
2018-08-30 | Fosun International Ltd | Buy | 2,702,702 | 9.25 | 24,999,993 |
2018-08-20 | Orbimed Capital Gp Iii Llc | Sale | 155,387 | 9.98 | 1,550,762 |
2018-08-16 | Orbimed Capital Gp Iii Llc | Sale | 366,220 | 9.94 | 3,640,226 |
2018-08-15 | Orbimed Capital Gp Iii Llc | Sale | 78,050 | 9.93 | 775,036 |
2018-08-14 | Orbimed Capital Gp Iii Llc | Sale | 20,975 | 9.94 | 208,491 |
2018-08-13 | Orbimed Capital Gp Iii Llc | Sale | 86,923 | 9.98 | 867,491 |
2018-08-10 | Orbimed Capital Gp Iii Llc | Sale | 684,793 | 9.96 | 6,820,538 |
2018-08-09 | Orbimed Capital Gp Iii Llc | Sale | 201,343 | 9.91 | 1,994,705 |
2018-08-09 | Orbimed Capital Gp Iii Llc | Option Ex | 65,190 | 5.00 | 325,950 |
2018-08-08 | Orbimed Capital Gp Iii Llc | Sale | 482,660 | 10.00 | 4,826,600 |
2018-08-08 | Fmr Llc (Other) | Sale | 200,000 | 10.02 | 2,004,000 |
2018-08-07 | Orbimed Capital Gp Iii Llc | Sale | 50,627 | 10.01 | 506,776 |
2018-08-07 | Orbimed Capital Gp Iii Llc | Option Ex | 26,388 | .00 | 0 |
2018-08-07 | Fmr Llc (Other) | Sale | 26,600 | 10.19 | 271,054 |
2018-08-06 | Fmr Llc (Other) | Sale | 147,329 | 10.60 | 1,561,392 |
2018-08-03 | Orbimed Capital Gp Iii Llc | Sale | 119,293 | 11.71 | 1,396,921 |
2018-08-03 | Fmr Llc (Other) | Sale | 255,153 | 11.36 | 2,897,262 |
2018-08-02 | Fmr Llc (Other) | Sale | 79,522 | 12.04 | 957,206 |
2018-08-01 | Fmr Llc (Other) | Sale | 66,334 | 12.02 | 797,003 |
2018-07-31 | Fmr Llc (Other) | Sale | 60,872 | 12.10 | 736,551 |
2018-07-30 | Fmr Llc (Other) | Sale | 110,000 | 11.45 | 1,259,830 |
2018-07-27 | Fmr Llc (Other) | Sale | 148,565 | 11.58 | 1,720,382 |
2018-07-26 | Fmr Llc (Other) | Sale | 218,811 | 12.35 | 2,701,659 |
2018-07-25 | Fmr Llc (Other) | Sale | 77,039 | 11.97 | 922,542 |
2018-03-14 | Dempsey James F. (Chief Scientific Officer) | Sale | 75,243 | 7.57 | 569,739 |
2018-03-14 | Dempsey James F. (Chief Scientific Officer) | Option Ex | 75,243 | .80 | 60,194 |
2017-12-01 | Gold Mark Stephen | Option Ex | 25,104 | 2.95 | 74,056 |
2017-04-25 | Fmr Llc (Other) | Sale | 106,781 | 6.75 | 720,344 |
2017-04-24 | Fmr Llc (Other) | Sale | 77,634 | 6.63 | 514,868 |
2017-04-21 | Fmr Llc (Other) | Sale | 23,505 | 6.87 | 161,479 |
2017-04-20 | Fmr Llc (Other) | Sale | 72,972 | 6.95 | 507,301 |
2017-04-19 | Fmr Llc (Other) | Sale | 28,264 | 6.95 | 196,350 |
2017-04-18 | Fmr Llc (Other) | Sale | 17,517 | 7.10 | 124,370 |
2017-04-17 | Fmr Llc (Other) | Sale | 89,700 | 7.53 | 675,261 |
2017-04-13 | Fmr Llc (Other) | Sale | 115,860 | 7.52 | 871,614 |
2017-04-12 | Fmr Llc (Other) | Sale | 97,680 | 7.41 | 723,808 |
2017-04-11 | Fmr Llc (Other) | Sale | 81,814 | 7.49 | 612,786 |
2017-04-10 | Fmr Llc (Other) | Sale | 178,556 | 7.72 | 1,377,916 |
2017-04-07 | Fmr Llc (Other) | Sale | 48,950 | 7.96 | 389,446 |
2017-04-06 | Fmr Llc (Other) | Sale | 3,100 | 7.73 | 23,963 |
2017-04-05 | Fmr Llc (Other) | Sale | 63,630 | 7.80 | 496,314 |
2017-04-04 | Fmr Llc (Other) | Sale | 132,767 | 7.95 | 1,055,497 |
2017-04-03 | Fmr Llc (Other) | Sale | 104,006 | 7.97 | 829,447 |
2017-03-31 | Fmr Llc (Other) | Sale | 113,877 | 8.61 | 980,253 |
2017-03-30 | Fmr Llc (Other) | Sale | 28,661 | 8.46 | 242,472 |
2017-01-18 | Bonita David P | Buy | 330,577 | 3.00 | 991,731 |
2017-01-18 | Gold Mark Stephen | Buy | 78,246 | 3.17 | 248,039 |
2017-01-18 | Bansal Ajay (Chief Financial Officer) | Buy | 62,597 | 3.17 | 198,432 |
2017-01-18 | Mckinnell Henry A | Buy | 312,989 | 3.17 | 992,175 |
2017-01-18 | Isaly Samuel D | Buy | 330,577 | 3.00 | 991,731 |
2016-09-09 | Puri Aditya | Buy | 1,472,803 | 2.95 | 4,344,768 |
2016-08-22 | Bonita David P | Buy | 1,138,074 | 2.95 | 3,357,318 |
2016-08-22 | Gold Mark Stephen | Buy | 83,682 | 2.95 | 246,861 |
2016-08-22 | Mckinnell Henry A | Buy | 334,728 | 2.95 | 987,447 |
2016-08-22 | Isaly Samuel D | Buy | 1,138,074 | 2.95 | 3,357,318 |
Insider trading activities including stock purchases, stock sales, and option exercises of VRAY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viewray, Inc. (symbol VRAY, CIK number 1597313) see the Securities and Exchange Commission (SEC) website.